A crucial element of regenerative treatment and drug research lies in the ability to multiply human stem cell groups to sufficient amounts for therapeutic purposes. Traditionally, constrained cell supply posed a significant obstacle to development in these fields. Consequently, considerable endeavor has been directed towards improving procedures fo